NCT04785066View on ClinicalTrials.gov

Efficacy of Pulmozyme® on Arterial Recanalization in Post-thrombectomy Patients Managed for Ischemic Stroke (NETs-target)

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 19, 2022

Primary Completion Date

August 18, 2025

Study Completion Date

August 18, 2025

Conditions
Ischemic Stroke
Interventions
DRUG

Administration of dornase alfa

Patient treated for a cerebral thrombectomy will be administred dornase alfa treatment by intravenous

Trial Locations (1)

75019

Hôpital Fondation Adolphe de Rothschild, Paris

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK